Oxford University testing vaccine in children

PTI | London | Updated: 13-02-2021 18:14 IST | Created: 13-02-2021 16:39 IST
Oxford University testing vaccine in children
Representative image Image Credit: ANI

The University of Oxford plans to test its COVID-19 vaccine in children for the first time, becoming the latest vaccine developer to assess whether its coronavirus shot is effective in young people.

The trial announced Saturday seeks to recruit 300 volunteers between the ages of 6 and 17, with up to 240 receiving the COVID-19 vaccine and the remainder a control meningitis vaccine.

Andrew Pollard, chief researcher on the Oxford vaccine trial, says that while most children don't get severely ill from COVID-19, "it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination.'' Regulators in more than 50 countries have authorized widespread use of the Oxford vaccine, which is being produced and distributed by AstraZeneca, for use in people over the age of 18.

Other drug companies are also testing the COVID-19 vaccines in children. Pfizer, whose vaccine has already been authorized for use in people 16 and older, began testing its shot in children as young as 12 in October. Moderna in December began testing its vaccine on children as young as 12.

Pollard said the Oxford trial should help policymakers decide whether at some point in the future they want to extend mass vaccination programs to children as they seek to ensure schools are safe and combat the spread of the virus in the wider population.

"For most children, for themselves, COVID is really not a big problem…,'' Pollard told The Associated Press. "However, it is certainly possible that wider use to try and curb the progress of the pandemic might be considered in the future, so here we're just trying to establish the data that would support that if indeed policymakers wanted to go in that direction."

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)



Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...


Latest News

Centre should have listened to Rahul Gandhi's advise on COVID-19, says Digambar Kamat

Hitting out at the Centre over surge in coronavirus cases, Goa Leader of Opposition LoP Digambar Kamat on Wednesday said that if the government had listened to the valuable suggestions of Congress leader Rahul Gandhi then the COVID-19 situa...

K Madhavan elevated as President of Disney, Star India

The Walt Disney Company India and Star India on Wednesday elevated K Madhavan naming him the president of both the firms, effective immediately.Since 2019, Madhavan has been the country manager for Star and Disney in India, overseeing their...

West Bengal govt to start probe into Cooch Behar killings to

West Bengal Chief Minister Mamata Banerjee on Wednesday met familes of those killed in CISF firing during the fourth phase of assembly elections and asserted that her government will launch a probe to bring the culprits to book.Banerjee lam...

Hashish oil worth Rs 3 cr seized from hotel in Kerala

Hashish oil valued at Rs 3 crore was seized from a hotel in nearby Ramanattukara and one person arrested in this connection, Excise officials said on Wednesday.The recovery came after specific information that high- grade narcotic substance...

Give Feedback